| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 03/14/2013 | US20130062597 Nitrogen-containing heteroaromatic ring compound |
| 03/14/2013 | CA2848148A1 Benzonitrile derivatives as kinase inhibitors |
| 03/14/2013 | CA2846503A1 Use of 1h-quinazoline-2,4-diones for use in the prevention or treatment of photosensitive epilepsy |
| 03/13/2013 | EP2567957A1 Compounds for the treatment of dyslipidemia and related diseases |
| 03/13/2013 | EP2566862A1 Benzofuranyl analogues as gpr119 modulators |
| 03/13/2013 | EP2566861A1 Modulators of fatty acid amide hydrolase |
| 03/13/2013 | EP2566857A1 Aromatic monomers deriving from glycerol units, process for their preparation and use thereof for the preparation of water-soluble conjugated polymers |
| 03/13/2013 | EP2566477A1 Amino-quinolines as kinase inhibitors |
| 03/13/2013 | CN102971310A (3 -methylpyrrolidin- 3 - yl) methyl pyridinyl ether derivatives and their use as nk-3 receptor antagonists |
| 03/13/2013 | CN102971302A 6-acyl-1,2,4-triazine-3,5-dione derivative and herbicides |
| 03/13/2013 | CN102964341A Production system of triglycidyl isocyanurate |
| 03/13/2013 | CN102964340A Selective dopamine D1 receptor stimulants for treating Alzheimer disease |
| 03/13/2013 | CN102964339A Novel pharmaceutical salt of lapatinib |
| 03/13/2013 | CN102964305A Chiral tetrahydroimidazolidine compound with CnFmH2n+1-m structure unit and synthesis method thereof |
| 03/13/2013 | CN102964304A Preparation method of chiral amino cyanide containing pyrazolidone structure |
| 03/13/2013 | CN102964294A Pyridyl inhibitors of hedgehog signalling |
| 03/13/2013 | CN102964239A Metallo-beta-lactamase inhibitor |
| 03/13/2013 | CN102964232A Preparation method of ketone compound and its derivatives |
| 03/13/2013 | CN101928274B Peperphentonamine derivative |
| 03/13/2013 | CN101094848B Organic compounds |
| 03/12/2013 | US8394828 Quinoline-derived amide modulators of vanilloid VR1 receptor |
| 03/12/2013 | US8394794 Therapeutic compounds |
| 03/12/2013 | US8394510 Aromatic amine derivative and organic electroluminescence device using the same |
| 03/12/2013 | CA2731773C Amidophenoxyindazoles useful as inhibitors of c-met |
| 03/12/2013 | CA2640534C 1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of mglur2-receptors |
| 03/12/2013 | CA2637933C Indole sulfonamide modulators of progesterone receptors |
| 03/12/2013 | CA2569763C 2,4-diaminoquinazolines for spinal muscular atrophy |
| 03/12/2013 | CA2551227C Acidic quinoline derivatives and their use for the prevention and/or treatment of hyperglycaemia-related pathologies |
| 03/12/2013 | CA2537936C Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-ht1f agonists |
| 03/12/2013 | CA2388505C 5-membered heterocycle derivatives, their preparation and application as medicine |
| 03/07/2013 | WO2013033377A1 Aldh-2 inhibitors in the treatment of addiction |
| 03/07/2013 | WO2013032297A1 Benzocarbazole compounds and electroluminescent devices involving them |
| 03/07/2013 | WO2013032284A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 03/07/2013 | WO2013031922A1 Pyrazole compound and use thereof for medical purposes |
| 03/07/2013 | WO2013031794A1 Organic electroluminescence element, display device, and illumination device |
| 03/07/2013 | WO2013031527A1 Light-emitting element, light-emitting device, electronic device, lighting device, and heterocyclic compound |
| 03/07/2013 | WO2013031520A1 Organic electroluminescence element |
| 03/07/2013 | WO2013031428A1 Novel compound having triazine side chain, colored composition, inkjet ink, inkjet recording method, color filter, and color toner |
| 03/07/2013 | WO2013030665A1 Pyrimidines as sodium channel blockers |
| 03/07/2013 | WO2013030367A1 Biphenylcarboxamides as rock kinase inhibitors |
| 03/07/2013 | WO2013030366A1 Novel soft rock inhibitors |
| 03/07/2013 | WO2013030365A1 Novel rock kinase inhibitors |
| 03/07/2013 | WO2013030216A1 Novel soft rock inhibitors |
| 03/07/2013 | WO2013030100A1 Method for producing tetrazole-substituted anthranilic acid diamide derivatives by reacting benzoxazinones with amines |
| 03/07/2013 | WO2013001505A3 Sulphonamide derivatives of alicyclic amines for the treatment of central nervous system diseases |
| 03/07/2013 | WO2012117000A8 3-amino-pyridines as gpbar1 agonists |
| 03/07/2013 | US20130059899 Methods of identifying modulators of gpr17 |
| 03/07/2013 | US20130059891 Substituted n-heterocycloalkyl bipyrrolidinylphenyl amide derivatives, preparation and therapeutic use thereof |
| 03/07/2013 | US20130059873 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv) |
| 03/07/2013 | US20130059871 Pyrimidine derivatives for the treatment of amyloid-related diseases |
| 03/07/2013 | US20130059860 Naphthalene carboxamide m1 receptor positive allosteric modulators |
| 03/07/2013 | US20130059858 Benzofuranyl analogues as gpr119 modulators |
| 03/07/2013 | US20130059853 Biaryl phosphodiesterase inhibitors |
| 03/07/2013 | US20130059731 Novel solid form of 4-[[(6-chloropyridin-3-yl)methyl](2,2-difluoroethyl)amino]furan-2(5h)-one |
| 03/07/2013 | US20130056720 Compound for organic optoelectronic device, organic light emitting diode including the same and display including the organic light emitting diode |
| 03/07/2013 | CA2846752A1 Biphenylcarboxamides as rock kinase inhibitors |
| 03/07/2013 | CA2846695A1 Novel soft rock inhibitors |
| 03/07/2013 | CA2846694A1 Novel rock kinase inhibitors |
| 03/07/2013 | CA2846463A1 Pyrimidines as sodium channel blockers |
| 03/07/2013 | CA2846116A1 Novel compound having triazine side chain, coloring composition, inkjet ink, inkjet recording method, color filter, and color toner |
| 03/07/2013 | CA2845796A1 Aldh-2 inhibitors in the treatment of addiction |
| 03/07/2013 | CA2845127A1 Pyrazole compound and pharmaceutical use thereof |
| 03/07/2013 | CA2844521A1 Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
| 03/06/2013 | EP2565192A1 Anticancer agent |
| 03/06/2013 | EP2565191A1 4-(Indol-7-ylcarbonylaminomethyl)cyclohexanecarboxylic acid derivatives as EP4 receptor antagonists useful for the treatment of chronic renal failure or diabetic nephropathy |
| 03/06/2013 | EP2565185A1 [5,6]heterocyclic compound |
| 03/06/2013 | EP2564706A1 Anthranilamide insecticides |
| 03/06/2013 | EP2563778A1 Solid forms of (r)-1(2,2 -difluorobenzo[d][1,3]dioxol-5yl)-n-(1-(2,3-dihyderoxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2yl)-1h-indol-5yl)cyclopropanecarboxamide |
| 03/06/2013 | EP2563777A2 Inverse agonists and neutral antagonists for the tsh receptor |
| 03/06/2013 | EP2563776A2 Compounds that modulate intracellular calcium |
| 03/06/2013 | EP2563775A1 Pyrazolyl quinazoline kinase inhibitors |
| 03/06/2013 | CN102958919A Novel tetrahydroquinoline derivatives |
| 03/06/2013 | CN102958918A Novel nicotinamide derivatives or salts thereof |
| 03/06/2013 | CN102958914A 1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin D2 receptor modulators |
| 03/06/2013 | CN102952122A Compound used in color composition |
| 03/06/2013 | CN102952121A Improved preparation method for piperazine derivant |
| 03/06/2013 | CN102952118A Poly(ADP-ribose)polymerase inhibitor, preparation method and application thereof |
| 03/06/2013 | CN102952109A Compound used in color composition |
| 03/06/2013 | CN102952059A Amide derivative and preparation method thereof, medicine composition and application |
| 03/06/2013 | CN102952033A Novel compound, composing method thereof and therapeutic use therefor |
| 03/06/2013 | CN102950143A Processing method of solid salt waste during production of triglycidyl isocyanurate |
| 03/06/2013 | CN102285973B Paroxetine hydrochloride compound and preparation method thereof |
| 03/06/2013 | CN101687842B Modulators of CFTR |
| 03/06/2013 | CN101374832B Use of 4-imidazole derivatives for CNS disorders |
| 03/06/2013 | CN101098859B Pyrimidinone compound, preparation and application thereof |
| 03/05/2013 | USRE44048 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-YL]benzenesulfonamide for the treatment of inflammation or an inflammation-associated disorder |
| 03/05/2013 | US8389730 Compositions and methods for the treatment of disease associated with TRP-P8 expression |
| 03/05/2013 | US8389720 Quinolone neuropeptide S receptor antagonists |
| 03/05/2013 | US8389570 Hydroxamates as therapeutic agents |
| 03/05/2013 | US8389559 Pyrrolidine triple reuptake inhibitors |
| 03/05/2013 | US8389442 N-phenyl-′(4-pyridyl)-azinyl!amine derivatives as plant protection agents |
| 03/05/2013 | CA2587429C 5-aminopyrazole derivatives as pesticidal compounds |
| 03/05/2013 | CA2569883C Aroyl-o-piperidine derivatives for the treatment of diabetes-related problems |
| 02/28/2013 | WO2013027845A1 Radiolabeled compounds and their use as radiotracers for quantitative imaging of phosphodiesterase (pde10a) in mammals |
| 02/28/2013 | WO2013027196A1 Substituted 2-alkyl-1-oxo-n-phenyl-3-heteroaryl-1,2,3,4- tetrahydroisoquinoline-4-carboxamides for antimalarial therapies |
| 02/28/2013 | WO2013027168A1 Novel heterocyclic compounds as bromodomain inhibitors |
| 02/28/2013 | WO2013026900A1 Pyridine derivatives as microbiocides |
| 02/28/2013 | WO2013026163A1 Hepatitis c inhibitor compounds |
| 02/28/2013 | WO2012158811A3 Purine monophosphate prodrugs for treatment of viral infections |
| 02/28/2013 | US20130053564 Ketal amide compounds, methods of making, and applications |